Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. PINK /
  3. MDCLF.PINK

MedinCell S.A (MDCLF PINK) stock market data APIs

$6.976 0(0%) as of July 26, 2024
Price chart is built with Anychart

MedinCell S.A., a pharmaceutical company, develops long acting injectables in various therapeutic areas in France. It develops solutions based on BEPO, a long-acting injectable technology. The company's products in development include mdc-IRM, a risperidone extended-release injectable suspension for use in the treatment of schizophrenia in adults; mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain and inflammation; and mdc-TJK, a subcutaneous injection that is in Phase III clinical trials for use in the treatment of schizophrenia. Its product candidates in preclinical trials include mdc-ANG, an antipsychotic product for use in the treatment of schizophrenia; mdc-TTG for Covid-19 and its variants; mdc-GRT for organ transplant; mdc-WWM for contraception; mdc-STM for malaria; and mdc-IRM for neuroscience. MedinCell S.A. was incorporated in 2003 and is based in Jacou, France.

MedinCell S.A Financial Data Overview

6.976
6.976
-
6.976
6.976
6.975-6.985
407 M
29 087 K
11 945 K
-0.2722
1.139
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'MDCLF',
Type: 'Common Stock',
Name: 'MedinCell S.A',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00YRKGWX7',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'March',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

MedinCell S.A Fundamental Data is available in our Financial Data APIs

  • Net Revenue 11 945 K
  • EBITDA -19 966 000
  • Earnings Per Share -1.34
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get MedinCell S.A Earnings via APIs

  • Latest Release 2021-09-30
  • EPS/Forecast 0

Get MedinCell S.A End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get MedinCell S.A latest news via APIs

MedinCell’s Partner Teva Announces Successful Launch of UZEDY™

MONTPELLIER, France, August 02, 2023--(BUSINESS WIRE)--MedinCell (Paris:MEDCL): Access here the complete press release During today’s Q2 earnings call, Richard Francis, President and CEO of Teva, ...

MedinCell has Received the Last Tranche of €10m from the European Investment Bank (EIB) Loan

MONTPELLIER, France, July 31, 2023--(BUSINESS WIRE)--Regulatory News: MedinCell (Paris:MEDCL): The drawdown of this last tranche of a 40 million euros total loan signed with the EIB in November 2022...
Do you have any questions?
support@eodhistoricaldata.com